Neurofibromatosis 2

Type 2 Neurofibromatosis are rare inherited autosomal dominant diseases caused by the NF2 gene. It is characterized by the growth of noncancerous tumors in the nervous system, specifically along the auditory nerve. Symptoms include hearing loss, tinnitus, and balance problems. Here is the latest research on Type 2 Neurofibromatosis.

September 14, 2021
Open Access

Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma

MedRxiv : the Preprint Server for Health Sciences
A. K. MattoxChetan Bettegowda
September 14, 2021
Case Report

Intradural Extramedullary Lesions in the Cervical Spine in Neurofibromatosis.

The American Journal of Case Reports
Rana Moshref, Abeer Mirdad
September 14, 2021

Clinical and Imaging Response to Trigeminal Schwannoma Radiosurgery: A Retrospective Analysis of a 28-Year Experience.

Journal of Neurological Surgery. Part B, Skull Base
Ajay NiranjanLawrence Dade Lunsford
September 9, 2021

Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomas.

Acta Neuropathologica
Elmar KirchesChristian Mawrin
August 26, 2021

A clinically applicable integrative molecular classification of meningiomas.

Farshad NassiriGelareh Zadeh
August 25, 2021
Case Report
Open Access

Complications of Neurofibromatosis 1 (NF1) in an Adult With Multiple Comorbidities.

Ozioma P Nnomadim, Blandine Bustamante Helfrich
August 20, 2021

Depression explains the association between pain intensity and pain interference among adults with neurofibromatosis.

Journal of Neuro-oncology
James D DoorleyAna-Maria Vranceanu
August 10, 2021

WHO grade III meningioma: De novo tumors show improved progression free survival as compared to secondary progressive tumors.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Jacob RuzevickManuel Ferreira
August 6, 2021
Open Access

Characterization of UMi031-A-2 inducible pluripotent stem cell line with a neurofibromatosis type 2-associated mutation.

Stem Cell Research
Aida NourbakhshXue Zhong Liu
August 6, 2021

Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas.

Journal of Neuro-oncology
Lan JinJennifer Moliterno
August 6, 2021

Revisiting the UK Genetic Severity Score for NF2: a proposal for the addition of a functional genetic component.

Journal of Medical Genetics
Núria CatasúsNF2 Spanish National Reference Centre HUGTP-ICO-IGTP
August 4, 2021

Clinical Characteristics and Magnetic Resonance Imaging-Based Prediction of the KLF4K409Q Mutation in Meningioma.

World Neurosurgery
Niklas von SpreckelsenRoland Goldbrunner
August 3, 2021
Open Access

Conformational flexibility determines the Nf2/merlin tumor suppressor functions.

Matrix Biology Plus
Marina C PrimiTina Izard
July 22, 2021
Case Report
Open Access

Pulmonary hypertension associated with neurofibromatosis type 2.

Pulmonary Circulation
Hirohisa TaniguchiYuichi Tamura
July 18, 2021
Open Access

Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes.

Human Mutation
Cristina Perez-BecerrilMiriam J Smith
July 15, 2021
Open Access

Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models.

Science Translational Medicine
Limeng WuLei Xu

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

4H Leukodystrophy

4H Leukodystrophy involves hypomyelination with hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3 Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. Here is the latest research on this disease.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Adult Polyglucosan Body Disease

Adult polyglucosan body disease (APBD) is a rare autosomal recessive disease characterized by defects in the glycogen brancher enzyme 1 (GBE1) gene. Discover the latest research on APBD here.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.

Bullous Pemphigoid

Bullous pemphigoid is a rare immune system disorder and skin condition that causes large, fluid-filled blisters. Bullous pemphigoid commonly affects older adults and appears in areas such as the lower abdomen, upper thighs or armpits. Discover the latest research on bullous pemphigoid here.

CLOVES Syndrome

Congenital, Lipomatous, Overgrowth, Vascular Malformations, Epidermal Nevi and Spinal/Skeletal Anomalies and/or Scoliosis (CLOVES) syndrome is a rare genetic disorder caused by mutations in the PIK3CA gene. Symptoms include blood vessel abnormalities, small tissue tumors, skin legions and spinal abnormalities. Here is the latest research on CLOVES syndrome.

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.

Cerebral Creatine Deficiency Syndromes

Cerebral creatine deficiency syndromes is a group of rare inherited disorders with three variants: Creatine Transporter Deficiency (CTD), Guanidinoacetate Methyltransferase Deficiency (GAMT) and L-Arginine: Glycine Amidinotransferase Deficiency (AGAT). Discover the latest research here.

© 2021 Meta ULC. All rights reserved